Abstract:The pterin-containing molybdenum enzymes are comprised of three general classes which perform simple oxygen-atom transfer either to or from substrate (sulfite oxidase and DMSO reductase families) and the oxidative hydroxylation of various substrates (xanthine oxidase family). 1 Following oxygen-atom transfer, the resting state of the enzyme is regenerated by two sequential one-electron transfers. Therefore, it is of interest to investigate electron transfer events in oxomolybdenum systems which mimic specific … Show more
“…The disadvantages associated with first generation PSs have led to extensive investigation aimed at improving the efficacy of PS molecules via alteration of the peripheral functionality of the porphyrin 33 , or direct modification of the porphyrin core 34 , The following the seminal works on the first generation PS have resulted in the production of several new non-porphyrinoid PS molecules ( Fig. 2 ).…”
Section: The Photosensitizers For Anticancer Pdtmentioning
Photodynamic therapy (PDT), based on the photoactivation of photosensitizers (PSs), has become a well-studied therapy for cancer. Photofrin®, belonging to the first generation of PS, is still widely used for the treatment of different kinds of cancers; however, it has several drawbacks that significantly limit its general clinical use. Consequently, there has been extensive research on the design of PS molecules with optimized pharmaceutical properties, with aiming of overcoming the disadvantages of traditional PS, such as poor chemical purity, long half-life, excessive accumulation into the skin, and low attenuation coefficients. The rational design of novel PS with desirable properties has attracted considerable research in the pharmaceutical field. This review presents an overview on the classical photosensitizers and the most significant recent advances in the development of PS with regard to their potential application in oncology.
“…The disadvantages associated with first generation PSs have led to extensive investigation aimed at improving the efficacy of PS molecules via alteration of the peripheral functionality of the porphyrin 33 , or direct modification of the porphyrin core 34 , The following the seminal works on the first generation PS have resulted in the production of several new non-porphyrinoid PS molecules ( Fig. 2 ).…”
Section: The Photosensitizers For Anticancer Pdtmentioning
Photodynamic therapy (PDT), based on the photoactivation of photosensitizers (PSs), has become a well-studied therapy for cancer. Photofrin®, belonging to the first generation of PS, is still widely used for the treatment of different kinds of cancers; however, it has several drawbacks that significantly limit its general clinical use. Consequently, there has been extensive research on the design of PS molecules with optimized pharmaceutical properties, with aiming of overcoming the disadvantages of traditional PS, such as poor chemical purity, long half-life, excessive accumulation into the skin, and low attenuation coefficients. The rational design of novel PS with desirable properties has attracted considerable research in the pharmaceutical field. This review presents an overview on the classical photosensitizers and the most significant recent advances in the development of PS with regard to their potential application in oncology.
“…Enemark and Kirk et al already demonstrated in an early study that a Mo center can be photoactivated via an antenna-mediated electron transfer process by covalently linking an oxo-Mo(V) unit to porphyrin-Fe(III) or Zn(II) complexes (Scheme 1a). 18,19 Although catalytic investigations were not reported for these dyads, the study highlighted photoactivation as a potential way of initiating intercomponent electron transfer. More recently, Heinze et al appended two redox-active ferrocene units to a cisdioxo-Mo(VI) complex to mimic the electron-transfer chain in the molybdenum enzyme sulfite oxidase (Scheme 1b).…”
Section: ■ Introductionmentioning
confidence: 91%
“…Since Mo is chosen by nature as OAT catalyst par excellence based on its ability to redox cycle between oxidation states VI, V, and IV, we are interested in utilizing bioinspired Mo complexes as catalysts in dyads designed to facilitate substrate oxidation via a photoredox process. Enemark and Kirk et al already demonstrated in an early study that a Mo center can be photoactivated via an antenna-mediated electron transfer process by covalently linking an oxo-Mo(V) unit to porphyrin-Fe(III) or Zn(II) complexes (Scheme a). , Although catalytic investigations were not reported for these dyads, the study highlighted photoactivation as a potential way of initiating intercomponent electron transfer. More recently, Heinze et al appended two redox-active ferrocene units to a cis -dioxo-Mo(VI) complex to mimic the electron-transfer chain in the molybdenum enzyme sulfite oxidase (Scheme b) .…”
Nature uses molybdenum-containing enzymes to catalyze oxygen atom transfer (OAT) from water to organic substrates. In these enzymes, the two electrons that are released during the reaction are rapidly removed, one at a time, by spatially separated electron transfer units. Inspired by this design, a Ru(II)-Mo(VI) dyad was synthesized and characterized, with the aim of accelerating the rate-determining step in the cis-dioxo molybdenum-catalyzed OAT cycle, the transfer of an oxo ligand to triphenyl phosphine, via a photo-oxidation process. The dyad consists of a photoactive bis(bipyridyl)-phenanthroline ruthenium moiety that is covalently linked to a bioinspired cis-dioxo molybdenum thiosemicarbazone complex. The quantum yield and luminescence lifetimes of the dyad [Ru(bpy)(L)MoO(solv)] were determined. The major component of the luminescence decay in MeCN solution (τ = 1149 ± 2 ns, 67%) corresponds closely to the lifetime of excited [Ru(bpy)(phen-NH)], while the minor component (τ = 320 ± 1 ns, 31%) matches that of [Ru(bpy)(H-L)]. In addition, the (spectro)electrochemical properties of the system were investigated. Catalytic tests showed that the dyad-catalyzed OAT from dimethyl sulfoxide to triphenyl phosphine proceeds significantly faster upon irradiation with visible light than in the dark. Methylviologen acts as a mediator in the photoredox cycle, but it is regenerated and hence only required in stoichiometric amounts with respect to the catalyst rather than sacrificial amounts. It is proposed that oxidative quenching of the photoexcited Ru unit, followed by intramolecular electron transfer, leads to the production of a reactive one-electron oxidized catalyst, which is not accessible by electrochemical methods. A significant, but less pronounced, rate enhancement was observed when an analogous bimolecular system was tested, indicating that intramolecular electron transfer between the photosensitizer and the catalytic center is more efficient than intermolecular electron transfer between the separate components.
“…13 Enemark and Kirk et al demonstrated that oxo-molybdenum(V) can be photoactivated via an antenna-mediated eT process by covalently linking the oxo-Mo(V) unit to porphyrin-Fe (III) or Zn(II) complexes. 14,15 Recently, Duhme-Klair et al developed biomimetic molybdenum complexes 16 with appended ruthenium-based photoactive units to facilitate oxygen atom transfer (OAT) catalysis via photo-induced eT ( Fig. 1).…”
Photo-induced oxidation-enhancement in biomimetic bridged Ru(II)-Mo(VI) photo-catalyst is unexpectedly photo-activated in ps timescales. One-photon absorption generates an excited state where both photo-oxidized and photo-reduced catalytic centres are activated simultaneously and...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.